CannTrust
CannTrust
CNTTQ
OTC
0.63
USD
0.00%
About
CannTrust Holdings Inc. is a holding company. The Company’s primary asset is comprised of an approximately 10% equity interest in Phoena Holdings Inc. (Phoena). Phoena is a licensed cannabis producer, with locations in Vaughan and Fenwick, Ontario. Phoena operates a portfolio of brands, including estora, Liiv, SYNR.G and Xscape.
It has four brands in the medical and recreational spaces. It offers a variety of dried flowers, pre-rolls, cannabis oils, capsules, topical gels and sublingual strips..
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 0 |
| Three Month Average Volume | 5.7M |
| High Low | |
| Fifty-Two Week High | 6.03309 USD |
| Fifty-Two Week Low | 0.33053 USD |
| Fifty-Two Week High Date | 14 May 2019 |
| Fifty-Two Week Low Date | 09 Mar 2020 |
| Price and Volume | |
| Current Price | 0.63323 USD |
| Beta | -100,000 |
| Relative Price Change | |
| Four Week Relative Price Change | -8.08% |
| Thirteen Week Relative Price Change | -20.89% |
| Twenty-Six Week Relative Price Change | -34.30% |
| Fifty-Two Week Relative Price Change | -87.36% |
| Year-to-Date Relative Price Change | -12.64% |
| Price Change | |
| One Day Price Change | 0.00% |
| Thirteen Week Price Change | -33.09% |
| Twenty-Six Week Price Change | -41.67% |
| Five Day Price Change | 0.00% |
| Fifty-Two Week Price Change | -88.65% |
| Year-to-Date Price Change | -24.17% |
| Month-to-Date Price Change | 0.00% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 1.14666 USD |
| Book Value Per Share (Most Recent Quarter) | 1.25273 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 1.14666 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 1.25273 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.13646 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.31992 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.36263 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -69585.83474 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -69585.83474 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.095 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.08461 USD |
| Normalized (Last Fiscal Year) | -0.1385 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.095 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.08245 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.095 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.08461 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.47472 USD |
| Cash Per Share (Most Recent Quarter) | 0.28158 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.06639 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.04918 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.48798 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -100,000 |
| Cash Flow Revenue (Trailing Twelve Months) | -135 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -8.63% |
| Pretax Margin (Last Fiscal Year) | -26.55% |
| Pretax Margin (5 Year) | -99,999.99% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 56.86% |
| Gross Margin (Trailing Twelve Months) | 48.84% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -22.32% |
| Operating Margin (Trailing Twelve Months) | -7.97% |
| Operating Margin (5 Year) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -29.69% |
| Net Profit Margin (Trailing Twelve Months) | -22.31% |
| Net Profit Margin (5 Year) | -99,999.99% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 114.97% |
| Revenue Growth (3 Year) | -99,999.99% |
| Revenue Change (Trailing Twelve Months) | 114.31% |
| Revenue Per Share Growth | -99,999.99% |
| Revenue Growth (5 Year) | 321.68% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -1.08% |
| EPS Change (Trailing Twelve Months) | -160.29% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -27,151,320 |
| Net Debt (Last Fiscal Year) | -57,998,240 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 3 |
| Price to Sales (Trailing Twelve Months) | 2 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 6 |
| Long Term Debt to Equity (Most Recent Quarter) | 1 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 5 |
| Quick Ratio (Most Recent Quarter) | 3 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 8 |
| Current Ratio (Most Recent Quarter) | 6 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -53,466,050 |
| Free Cash Flow (Trailing Twelve Months) | -73,552,820 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -69 |
| Net Interest Coverage (Trailing Twelve Months) | -91 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 8 |
| Total Debt to Equity (Most Recent Quarter) | 8 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -9.65% |
| Return on Assets (Trailing Twelve Months) | -7.34% |
| Return on Assets (5 Year) | -99,999.99% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -11.07% |
| Return on Equity (Trailing Twelve Months) | -8.75% |
| Return on Equity (5 Year) | -99,999.99% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -10.54% |
| Return on Investment (Trailing Twelve Months) | -8.18% |
| Return on Investment (5 Year) | -99,999.99% |